RT Journal Article SR Electronic T1 Phylogenetic analysis of streptococci in samples taken from the throat cultures of children in Turkey and the presence of mef(A), mef(E), erm(B) and erm(TR) genes in patients with Streptococcus pyogenes JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.09.22.20196410 DO 10.1101/2020.09.22.20196410 A1 Çiğdem Eda Balkan A1 Hayrunisa Bekis Bozkurt A1 Cem Öziç YR 2020 UL http://medrxiv.org/content/early/2020/09/23/2020.09.22.20196410.abstract AB Objective Failure to achieve success with penicillin treatment in some cases observed in the pediatric group and the decrease in macrolide activity have brought about the necessity of a new study aiming to differentiate bacteria at the species level in throat infections. Antibiotic resistance studies are of great importance for the treatment of bacterial infections in terms of public health and rational antibiotic use. For this purpose, we aimed to perform a species-level differentiation of streptococci isolated from the throat cultures of pediatric patients presenting to our hospital, to determine their antibiotic susceptibility, and to identify the macrolide resistance genes of mef(A), mef(E), erm(B) and erm(TR) in patients with Streptococcus pyogenes. The study included 51 samples taken from pediatric cases presenting with a sore throat as the patient group and 36 samples from children without this complaint as the control group.Material and Method The throat culture samples taken from 51 children presenting to the hospital with the complaint of sore throat were evaluated in the laboratory, and streptococcus was diagnosed using tests; gram staining, catalase and PYR, and the susceptibility profile was determined with the Kirby-Bauer disk-diffusion method. Bacteria were identified at the species level according to 16srRNA sequences, and possible macrolide resistance genes of mef(A), mef(E), erm(B) and erm(TR) were determined by PCR in species detected to have S. pyogenes.Results Our antibiotic susceptibility results were consistent with the general results reported in Turkey. The sequence analysis of bacteria was performed according to 16srRNA sequences, and S. pyogenes, Streptococcus pneumoniae, Streptococcus anginosus, Streptococcus agalactiae, and Streptococcus dysgalactiae were isolated. In patients with S. pyogenes, the genetic determinants of macrolide resistance, mef(A), mef(E), erm(B) and erm(TR), were investigated with the PCR method using primers specific to each gene. Different levels of expression were observed in five patients. Macrolide resistance in S. pyogenes, which is reported at various percentages in the world, was found to be 9.8% in our study.Discussion The results of our study show that penicillin resistance genes were found in five of the patients evaluated. When the anamnesis of these patients was examined, it was determined that there were patients that frequently presented to the hospital with throat infections and experienced re-infection within a few weeks after receiving treatment. The common discourse of clinicians is that there may be an unknown resistance development. Therefore, our research should be supported by new hypotheses and studies that are open to development.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was financially supported by the Scientific Research Projects Unit of Kafkas University with the project number 2018TS67Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:8057635-050-99/88 Kafkas University Medical Commitee Ethical approval number.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript available.